MedTrace Logo

Vitamin and Unsaturated Fatty Acid Supplements in Healthy and Uveitis Human Subjects

NCT06491979 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2024-11-07

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if dietary supplements containing vitamin and unsaturated fatty acid works to intervene T cell inflammatory factor expression in patients with uveitis and healthy subjects in adults.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin A treatment

Vitamin A, 32 microgram per kilograms (of body weight) per day, for three weeks

DIETARY_SUPPLEMENT

Monounsaturated fatty acid mixture

Monounsaturated fatty acid mixture (mainly Omega-7, Omega-9), 47 milligrams per kilogram (of body weight) per day, for three weeks

DIETARY_SUPPLEMENT

Polyunsaturated fatty acid mixture

Polyunsaturated fatty acid mixture (mainly Omega-3, Omega-6), 6 milligrams per kilogram (of body weight) per day, for three weeks

DIETARY_SUPPLEMENT

Fatty acid mixture

Fatty acid mixture (mainly saturated fatty acid, Omega-6, Omega-7, Omega-9), 83 milligrams per kilogram (of body weight) per day, for three weeks

Sponsors & Collaborators

  • Tianjin Medical University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-15
Primary Completion
2024-08-17
Completion
2024-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06491979 on ClinicalTrials.gov